Jan 24, 2017 14:00 pm UTC| Business
CATSKILL, N.Y., Jan. 24, 2017 -- Greene County Bancorp, Inc. (the “Company”) (NASDAQ:GCBC), the holding company for The Bank of Greene County and its subsidiary Greene County Commercial Bank, today reported net income...
StandardVision Announces Strategic Investment by Eldridge Industries
Jan 24, 2017 14:00 pm UTC| Business
LOS ANGELES, Jan. 24, 2017 -- StandardVision, LLC(“StandardVision” or “the Company”) (www.standardvision.com), a quickly-growing integrated media solutions company, announced today a strategic investment by Eldridge...
Decisiv Continues Revolutionizing Industrial IoT Service Event Management For Commercial Assets
Jan 24, 2017 14:00 pm UTC| Business
GLEN ALLEN, Va., Jan. 24, 2017 -- Decisiv, Inc., the leader in Service Relationship Management (SRM) and provider of the first Industrial IoT PaaS solution for commercial asset service management, announced today...
SANUWAVE Issued U.S. Patent for a Shock Wave Applicator Construction With Movable Electrode
Jan 24, 2017 14:00 pm UTC| Business
SUWANEE, Ga., Jan. 24, 2017 -- SANUWAVE Health, Inc. (OTCBB:SNWV) today announced that the U.S. Patent and Trademark Office (USPTO) has issued the Company patent number 9,522,011, titled “Shock Wave Applicator with...
QFX Introducing Unfold & Go™ Electric Bike
Jan 24, 2017 14:00 pm UTC| Business
VERNON, Calif., Jan. 24, 2017 -- QFX USA is very pleased to announce the introduction of the BIK-6 Unfold Go™ Electric Personal Transportation Device. The BIK-6 Folds up to 28” X 8” X 18” for easy storage and unfolds...
$54.28 Billion Implantable Medical Devices Market - Analysis and Trends & Forecasts 2016-2025
Jan 24, 2017 13:52 pm UTC| Business
Dublin, Jan. 24, 2017 -- Research and Markets has announced the addition of the "Implantable Medical Devices Market Analysis and Trends - Product, Material - Forecast to 2025" report to their offering. ...
Cascadian Therapeutics Prices $82.5 Million Concurrent Offerings of Common Stock and Preferred Stock
Jan 24, 2017 13:50 pm UTC| Business
SEATTLE, Jan. 24, 2017 -- Cascadian Therapeutics, Inc. (NASDAQ:CASC), a clinical-stage biopharmaceutical company, today announced the pricing of the previously announced concurrent but separate underwritten offerings of...